Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shoucheng Ning

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
International Journal of Radiation Oncology, Biology, Physics|March 28, 2006
Optimization of combination therapy of arsenic trioxide and fractionated radiotherapy for malignant gliomaShoucheng Ning, Susan J Knox
International Journal of Radiation Oncology, Biology, Physics|September 1, 2004
Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxideShoucheng Ning, Susan J Knox
Cancer Research|January 25, 2005
Darbepoietin alfa potentiates the efficacy of radiation therapy in mice with corrected or uncorrected anemiaShoucheng Ning, Cynthia Hartley, Graham Molineux, et al.
Cancer Research|September 16, 2010
Anti-alphav integrin monoclonal antibody intetumumab enhances the efficacy of radiation therapy and reduces metastasis of human cancer xenografts in nude ratsShoucheng Ning, Junqiang Tian, Deborah J Marshall, et al.
Radiation Research|January 5, 2002
The antiangiogenic agents SU5416 and SU6668 increase the antitumor effects of fractionated irradiationShoucheng Ning, Douglas Laird, Julie M Cherrington, et al.
Biochemical and Biophysical Research Communications|April 17, 2014
Novel nitric oxide generating compound glycidyl nitrate enhances the therapeutic efficacy of chemotherapy and radiotherapyShoucheng Ning, Mark Bednarski, Bryan Oronsky, et al.
Cancer Chemotherapy and Pharmacology|February 7, 2018
A note on improved statistical approaches to account for pseudoprogressionNacer Abrouk, Bryan Oronsky, Scott Caroen, et al.
Endocrine-Related Cancer|June 17, 2009
Lanreotide promotes apoptosis and is not radioprotective in GH3 cellsShoucheng Ning, Susan J Knox, Griffith R Harsh, et al.
Molecular Cancer Therapeutics|June 21, 2008
Anti-integrin monoclonal antibody CNTO 95 enhances the therapeutic efficacy of fractionated radiation therapy in vivoShoucheng Ning, Jeffrey A Nemeth, Rebecca L Hanson, et al.
Cancer Research|May 17, 2012
Dinitroazetidines are a novel class of anticancer agents and hypoxia-activated radiation sensitizers developed from highly energetic materialsShoucheng Ning, Mark Bednarski, Bryan Oronsky, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
International Journal of Radiation Oncology, Biology, Physics|March 28, 2006
Optimization of combination therapy of arsenic trioxide and fractionated radiotherapy for malignant gliomaShoucheng Ning, Susan J Knox
International Journal of Radiation Oncology, Biology, Physics|September 1, 2004
Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxideShoucheng Ning, Susan J Knox
Cancer Research|January 25, 2005
Darbepoietin alfa potentiates the efficacy of radiation therapy in mice with corrected or uncorrected anemiaShoucheng Ning, Cynthia Hartley, Graham Molineux, et al.
Cancer Research|September 16, 2010
Anti-alphav integrin monoclonal antibody intetumumab enhances the efficacy of radiation therapy and reduces metastasis of human cancer xenografts in nude ratsShoucheng Ning, Junqiang Tian, Deborah J Marshall, et al.
Radiation Research|January 5, 2002
The antiangiogenic agents SU5416 and SU6668 increase the antitumor effects of fractionated irradiationShoucheng Ning, Douglas Laird, Julie M Cherrington, et al.
Biochemical and Biophysical Research Communications|April 17, 2014
Novel nitric oxide generating compound glycidyl nitrate enhances the therapeutic efficacy of chemotherapy and radiotherapyShoucheng Ning, Mark Bednarski, Bryan Oronsky, et al.
Cancer Chemotherapy and Pharmacology|February 7, 2018
A note on improved statistical approaches to account for pseudoprogressionNacer Abrouk, Bryan Oronsky, Scott Caroen, et al.
Endocrine-Related Cancer|June 17, 2009
Lanreotide promotes apoptosis and is not radioprotective in GH3 cellsShoucheng Ning, Susan J Knox, Griffith R Harsh, et al.
Molecular Cancer Therapeutics|June 21, 2008
Anti-integrin monoclonal antibody CNTO 95 enhances the therapeutic efficacy of fractionated radiation therapy in vivoShoucheng Ning, Jeffrey A Nemeth, Rebecca L Hanson, et al.
Cancer Research|May 17, 2012
Dinitroazetidines are a novel class of anticancer agents and hypoxia-activated radiation sensitizers developed from highly energetic materialsShoucheng Ning, Mark Bednarski, Bryan Oronsky, et al.
Pageof 3